SMARCB1 and lung carcinoma: Therefore, by use of shSMARCB1, we downregulated SMARCB1 genetic expression (Fig. S2) and protein levels (Fig. 3A), identifying a significant decrease in MEOX2 expression and protein levels (Figs. S2, 3A) in A549 lung cancer cells.